Henning Gronbaek
Overview
Explore the profile of Henning Gronbaek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
309
Citations
6312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Rudolfsen J, Gluud L, Gronbaek H, Jensen M, Vyberg M, Olsen J, et al.
Ann Hepatol
. 2024 Jan;
29(3):101285.
PMID: 38272183
Introduction And Objectives: Studies on the societal burden of patients with biopsy-confirmed non-alcoholic fatty liver disease (NAFLD) are sparse. This study examined this question, comparing NAFLD with matched reference groups....
22.
Gronbaek H, Mellemkjaer A, Nielsen S, Magkos F
Hepatobiliary Surg Nutr
. 2023 Dec;
12(6):963-965.
PMID: 38115926
No abstract available.
23.
Kronborg T, Schierwagen R, Trost K, Gao Q, Moritz T, Bendtsen F, et al.
Hepatol Commun
. 2023 Dec;
7(12).
PMID: 38051553
Background: Patients with cirrhosis and portal hypertension face a high risk of complications. Besides their anti-inflammatory and antifibrotic effects, statins may reduce portal pressure and thus the risk of complications...
24.
Mellemkjaer A, Kjaer M, Haldrup D, Gronbaek H, Thomsen K
Eur J Intern Med
. 2023 Nov;
122:28-34.
PMID: 38008609
The novel term Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is proposed to replace non-alcoholic fatty liver disease (NAFLD) to highlight the close association with the metabolic syndrome. MASLD encompasses patients...
25.
Balcar L, Mandorfer M, Hernandez-Gea V, Procopet B, Meyer E, Giraldez A, et al.
J Hepatol
. 2023 Oct;
80(1):73-81.
PMID: 37852414
Background & Aims: Pre-emptive transjugular intrahepatic portosystemic shunt (TIPS) is the treatment of choice for high-risk acute variceal bleeding (AVB; i.e., Child-Turcotte-Pugh [CTP] B8-9+active bleeding/C10-13). Nevertheless, some 'non-high-risk' patients have...
26.
27.
Wild D, Gronbaek H, Navalkissoor S, Haug A, Nicolas G, Pais B, et al.
Eur J Nucl Med Mol Imaging
. 2023 Sep;
51(1):183-195.
PMID: 37721581
Purpose: We present the results of an open-label, phase I/II study evaluating the safety and efficacy of the novel somatostatin receptor (SSTR) antagonist [Lu]Lu-satoreotide tetraxetan in 40 patients with previously...
28.
Johnson K, Stemann Lau T, Dahl Baunwall S, Villadsen G, Guldbrand Rasmussen V, Gronbaek H, et al.
J Neuroendocrinol
. 2023 Aug;
35(10):e13327.
PMID: 37574797
Carcinoid heart disease (CHD) is a serious complication for patients with neuroendocrine tumors (NETs), and early detection is crucial. We aimed to investigate N-terminal pro-brain natriuretic peptide (NT-proBNP), chromogranin A...
29.
Egger M, Horvath A, Pruller F, Fickert P, Finkelman M, Kriegl L, et al.
Liver Int
. 2023 Jun;
43(9):1975-1983.
PMID: 37334864
Background & Aims: On a global scale, liver cirrhosis is attributable to ~1 million deaths per year. This systemic disease comes along with diverse sequelae, including microbiota alterations, increased gut...
30.
Braadland P, Bergquist A, Kummen M, Bossen L, Engesaeter L, Reims H, et al.
J Hepatol
. 2023 Jun;
79(4):955-966.
PMID: 37328069
Background And Aims: We previously demonstrated that people with primary sclerosing cholangitis (PSC) had reduced gut microbial capacity to produce active vitamin B6 (pyridoxal 5'-phosphate [PLP]), which corresponded to lower...